admin 管理员组

文章数量: 1184232


2024年12月27日发(作者:要上市了access)

3,3-Diaminobenzidine (DAB) Liquid Substrate

System

Catalog Number D7304

Storage Temperature 2–8 C

Product Description

The DAB (3,3-Diaminobenzidine tetrahydrochloride)

Liquid Substrate System has been developed for use in

immunohistological and immunoblotting procedures as

a precipitating substrate for the detection of peroxidase

activity. DAB is the immunohistological substrate of

choice because it produces an intense brown stain that

is easily observed visually. The end product is resistant

to alcohol, therefore, a variety of counterstains and

mounting media can be used with the DAB Liquid

Substrate System. The DAB Liquid Substrate System

provides all the chromogen and buffer/peroxide

solutions needed to produce a fast and convenient DAB

substrate solution. The DAB Liquid Substrate System

is not recommended for ELISA (multiwell) procedures.

Components

The DAB Liquid Substrate System consists of the

following reagents:

DAB Liquid Buffer 225 mL

(Catalog Number D7429)

10 DAB Liquid Chromagen 25 mL

(Catalog Number D7554)

The DAB Liquid Substrate System provides reagents

sufficient to prepare 250 mL of DAB Substrate Solution.

Equipment and Reagents Required but Not

Provided

 Test Tubes

 Pipette capable of delivering 1 mL

 Graduated cylinder to measure 9 mL

 Whatman

®

Puradisc 30 syringe filter units,

disposable, cellulose acetate, pore size 0.2 m,

(Catalog Number WHA10462701)

 Nickel(II) chloride hexahydrate (NiCl

2

 6H

2

O,

Catalog Number 223387) or Cobalt(II) chloride

hexahydrate (CoCl

2

 6H

2

O, Catalog Number

202185), 0.3% (w/v) solution for enhancement of

tissue stains

 Tris buffered saline (TBS, Catalog Number T5030)

for washing

Precautions and Disclaimer

This product is for Research Use Only. Not for Use in

Diagnostic Procedures. Please consult the Safety Data

Sheet for information regarding hazards and safe

handling practices.

Preparation Instructions

Prepare 10 mL of DAB Substrate Solution by adding

1 mL of 10 DAB Liquid Chromogen (Catalog Number

D7554) to 9 mL of DAB Liquid Buffer (Catalog

Number D7429). Mix well. For best results, use the

solution immediately.

DAB reactions may be enhanced by the addition of

NiCl

2

or CoCl

2

to the DAB Substrate Solution. Add

1 mL of a 0.3% (w/v) metal salt solution to 10 mL of

DAB Substrate Solution. The addition of a metal salt to

DAB changes the color from brown to black or blue-

black.

Occasionally DAB solutions may be hazy. The

haziness may be removed by filtering the DAB solution

through a 0.2 m filter.

Storage/Stability

The product ships on wet ice and storage at 2–8 C is

recommended. The reagents are stable for 12 months

after manufacture. See product labels for actual

expiration date.

Procedure

1. Cover tissue sections with 0.2–0.5 mL of the DAB

Substrate Solution.

2. DAB is a fast-reacting substrate. Monitor color

development carefully during the reaction to

prevent overdevelopment and high background.

The reaction may be stopped by gently washing the

slide in water or TBS.

3. When finished, dispose of any remaining DAB

Substrate Solution in a manner consistent with

proper hazardous material handling protocols for

your institution.

2

Troubleshooting

Background too high

1. Prior to the application of the primary antibody,

block the tissue with 10% (v/v) normal serum from

the host species of the second antibody.

2. Prior to antibody incubations, block endogenous

peroxidase by flooding the slides with a solution of

4 parts methanol to 1 part 3% H

2

O

2

solution.

3. Decrease the staining time.

4. Titer the conjugate to optimize the working dilution.

No color develops or color is too faint

1. Adjust the concentration of the primary antibody.

2. Adjust the concentration of the secondary antibody.

3. Determine if the enzyme conjugate is active.

4. Consider using an amplifying system such as

avidin-biotin.

5. Increase the staining time.

6. Determine if enzymatic treatment (unmasking) of

the antigen is required prior to application of the

primary antibody.

References

1. Nakane, P.K., and Pierce, G.B., Jr., J. Histochem.

Cytochem., 14(12), 929-931 (1966).

2. Trojanowski, J.Q. et al., J. Histochem. Cytochem.,

31, 1217-1223 (1983).

3. DeJong, A.S.H. et al., Histochem. J., 17(10), 1119-

1130 (1985).

4. Chu, N.M. et al., J. Histochem. Cytochem., 37(2),

257-263 (1989).

5. Merchenthaler, I. et al., “Silver Intensification in

Immunocytochemistry”, in Techniques in

Immunocytochemistry (Bullock, G., and Petrusz, P.,

eds.). Academic Press Ltd. (San Diego, CA: 1989),

pp. 217-252.

6. Hsu, S., and Soban, E., J. Histochem. Cytochem.,

30(10), 1079-1082 (1982).

Whatman is a registered trademark of GE Healthcare.

VNC,GCY,MAM 11/18-1

2018 Sigma-Aldrich Co. LLC. All rights reserved. SIGMA-ALDRICH is a trademark of Sigma-Aldrich Co. LLC, registered in the US and other

countries. Sigma brand products are sold through Sigma-Aldrich, Inc. Purchaser must determine the suitability of the product(s) for their

particular use. Additional terms and conditions may apply. Please see product information on the Sigma-Aldrich website at

and/or on the reverse side of the invoice or packing slip.


本文标签: 作者 上市